Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,423
Total Claims
$974K
Drug Cost
599
Beneficiaries
$1,627
Cost/Patient
Risk Score Breakdown 33/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+31%
Opioid rate vs peers
2.9% vs 2.2% avg
+15%
Cost per patient vs peers
$1,627 vs $1,411 avg
+6%
Brand preference vs peers
11.3% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.9%
Opioid Rate
423
Opioid Claims
$13K
Opioid Cost
24.6%
Long-Acting Rate
Brand vs Generic
Brand: 1,625 claims · $740K
Generic: 12,735 claims · $232K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 280 | $145K |
| Dulaglutide | 64 | $83K |
| Empagliflozin | 52 | $55K |
| Sitagliptin Phosphate | 103 | $52K |
| Semaglutide | 39 | $46K |
| Rivaroxaban | 85 | $46K |
| Insulin Aspart | 29 | $19K |
| Mirabegron | 26 | $16K |
| Umeclidinium Brm/Vilanterol Tr | 31 | $15K |
| Insulin Detemir | 22 | $15K |
| Insulin Degludec | 11 | $14K |
| Dronedarone Hcl | 31 | $12K |
| Budesonide/Formoterol Fumarate | 24 | $11K |
| Insulin Glargine,hum.Rec.Anlog | 24 | $11K |
| Divalproex Sodium | 210 | $9,408 |
Prescribing Profile
Patient Profile
79
Avg Age
53%
Female
1.36
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About